Chemical Reviews,
Journal Year:
2023,
Volume and Issue:
123(12), P. 7854 - 7889
Published: May 30, 2023
With
the
rising
diabetic
population,
demand
for
glucose
sensing
devices
has
also
been
on
an
increasing
trend.
Accordingly,
field
of
biosensors
diabetes
management
witnessed
tremendous
scientific
and
technological
advancements
since
introduction
first
enzymatic
biosensor
in
1960s.
Among
these,
electrochemical
hold
considerable
potential
tracking
dynamic
profiles
real
time.
The
recent
evolution
wearable
opened
opportunities
to
use
alternative
body
fluids
a
pain-free,
noninvasive
or
minimally
invasive
manner.
This
review
aims
present
comprehensive
report
about
status
promise
sensors
on-body
monitoring.
We
start
by
highlighting
importance
how
can
contribute
toward
its
effective
then
discuss
mechanisms,
such
over
time,
different
versions
targeting
various
biofluids,
multiplexed
optimal
management.
Finally,
we
focus
commercial
aspects
biosensors,
starting
with
existing
continuous
monitors,
followed
other
emerging
technologies,
concluding
key
prospects
personalized
connection
autonomous
closed-loop
artificial
pancreas.
Advanced Science,
Journal Year:
2021,
Volume and Issue:
8(16)
Published: June 3, 2021
A
closed-loop
system
that
can
mini-invasively
track
blood
glucose
and
intelligently
treat
diabetes
is
in
great
demand
for
modern
medicine,
yet
it
remains
challenging
to
realize.
Microneedles
technologies
have
recently
emerged
as
powerful
tools
transdermal
applications
with
inherent
painlessness
biosafety.
In
this
work,
the
first
time
authors'
knowledge,
a
fully
integrated
wearable
(IWCS)
based
on
mini-invasive
microneedle
platform
developed
situ
diabetic
sensing
treatment.
The
IWCS
consists
of
three
connected
modules:
1)
mesoporous
microneedle-reverse
iontophoretic
sensor;
2)
flexible
printed
circuit
board
control;
3)
microneedle-iontophoretic
insulin
delivery
component.
As
key
component,
microneedles
enable
painless
penetration
stratum
corneum,
implementing
subcutaneous
substance
exchange.
coupling
iontophoresis
significantly
enhances
extraction
enables
electrical
control.
This
demonstrated
accurately
monitor
fluctuations,
responsively
deliver
regulate
hyperglycemia
rat
model.
design
endows
highly
promising
improve
therapies
patients.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(7), P. 3372 - 3406
Published: Jan. 1, 2022
Skin
diseases
are
the
fourth
leading
cause
of
nonfatal
and
chronic
skin
diseases,
acting
as
a
global
burden
affecting
world
economy.
severely
impact
patients'
quality
life
have
influenced
their
physical
mental
state.
Treatment
these
disorders
with
conventional
methods
shows
lack
therapeutic
efficacy,
long
treatment
duration,
recurrence
condition,
systemic
side
effects
due
to
improper
drug
delivery.
However,
pitfalls
can
be
overcome
applications
advanced
nanocarrier-
microneedle
(MN)-based
transdermal
delivery
strategies
that
provide
efficient
site-specific
at
target
site.
These
more
effective
than
other
administration
routes
by
avoiding
first-pass
metabolism,
enhancing
concentration
in
local
lesions,
reducing
toxicity.
Compared
traditional
methods,
or
MN-based
systems
painless,
noninvasive,
minimum-invasive
require
no
expensive
equipment.
More
importantly,
they
introduce
functions,
including
increased
penetration
efficiency,
controlled
release
rates,
enhanced
targeting
abilities,
theranostic
functions.
Here,
emergence
versatile
for
various
drugs
is
reviewed,
focusing
on
design
principles,
advantages,
considerations
treating
diverse
psoriasis,
dermatitis,
melanoma,
diseases.
Moreover,
prospects
challenges
dermatological
summarized.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(17)
Published: April 7, 2022
Infectious
virus
outbreaks
pose
a
significant
challenge
to
public
healthcare
systems.
Early
and
accurate
diagnosis
is
critical
prevent
the
spread
of
virus,
especially
when
no
specific
vaccine
or
effective
medicine
available.
In
clinics,
most
commonly
used
viral
detection
methods
are
molecular
techniques
that
involve
measurement
nucleic
acids
proteins
biomarkers.
However,
clinic-based
require
complex
infrastructure
expensive
equipment,
which
not
suitable
for
low-resource
settings.
Over
past
years,
smartphone-based
point-of-care
testing
(POCT)
has
rapidly
emerged
as
potential
alternative
laboratory-based
clinical
diagnosis.
This
review
summarizes
latest
development
detection.
First,
POCT-based
diagnostic
compared,
both
rely
on
immunosensing
acid
Then,
various
POCT
techniques,
including
optical
biosensors,
electrochemical
other
types
biosensors
discussed.
Moreover,
this
covers
diagnostics
viruses
COVID-19,
Ebola,
influenza,
Zika,
HIV,
et
al.
Finally,
prospects
challenges
It
believed
will
aid
researchers
better
understand
current
achieving
ultimate
goal
containing
disease-causing
worldwide.
Sensors,
Journal Year:
2023,
Volume and Issue:
23(23), P. 9498 - 9498
Published: Nov. 29, 2023
Disease
diagnosis
and
monitoring
using
conventional
healthcare
services
is
typically
expensive
has
limited
accuracy.
Wearable
health
technology
based
on
flexible
electronics
gained
tremendous
attention
in
recent
years
for
patient
owing
to
attractive
features,
such
as
lower
medical
costs,
quick
access
data,
ability
operate
transmit
data
harsh
environments,
storage
at
room
temperature,
non-invasive
implementation,
mass
scaling,
etc.
This
provides
an
opportunity
disease
pre-diagnosis
immediate
therapy.
sensors
have
opened
a
new
area
of
personalized
by
accurately
measuring
physical
states
biochemical
signals.
Despite
the
progress
date
development
wearable
sensors,
there
are
still
several
limitations
accuracy
collected,
precise
diagnosis,
early
treatment.
necessitates
advances
applied
materials
structures
artificial
intelligence
(AI)-enabled
extract
target
signals
accurate
clinical
decision-making
efficient
care.
In
this
paper,
we
review
two
significant
aspects
smart
sensors.
First,
offer
overview
most
improving
sensor
performance
physical,
chemical,
biosensors,
focusing
materials,
structural
configurations,
transduction
mechanisms.
Next,
use
AI
combination
with
big
processing,
self-learning,
power-efficiency,
real-time
acquisition
intelligent
sensing
platform.
Finally,
present
challenges
future
opportunities
associated
Microsystems & Nanoengineering,
Journal Year:
2021,
Volume and Issue:
7(1)
Published: Sept. 29, 2021
Abstract
Diabetes
is
a
prevalent
chronic
metabolic
disease
with
multiple
clinical
manifestations
and
complications,
it
among
the
leading
causes
of
death.
Painless
continuous
monitoring
interstitial
glucose
highly
desirable
for
diabetes
management.
Here
we
unprecedentedly
show
an
integrated
microneedle
biosensing
device.
The
device
was
manufactured
3D
printing
process,
microfabrication
electroplating
enzyme
immobilization
step.
inserted
into
dermis
layer
mouse
skin
showed
accurate
sensing
performance
subcutaneous
levels
in
normal
or
diabetic
mice.
detection
results
were
correlated
those
obtained
from
commercial
blood
meter.
We
anticipate
that
study
could
open
exciting
avenues
managing
diabetes,
alongside
fundamental
studies
electronic
devices.
Advanced Healthcare Materials,
Journal Year:
2022,
Volume and Issue:
11(10)
Published: Jan. 16, 2022
Abstract
Theranostic
system
combined
diagnostic
and
therapeutic
modalities
is
critical
for
the
real‐time
monitoring
of
disease‐related
biomarkers
personalized
therapy.
Microneedles,
as
a
multifunctional
platform,
are
promising
transdermal
diagnostics
drug
delivery.
They
have
shown
attractive
properties
including
painless
skin
penetration,
easy
self‐administration,
prominent
effects,
good
biosafety.
Herein,
an
overview
microneedles‐based
diagnosis,
therapies,
theranostic
systems
given.
Four
detection
methods
concluded
based
on
sensing
mechanism:
i)
electrochemistry,
ii)
fluorometric,
iii)
colorimetric,
iv)
Raman
methods.
Additionally,
robust
microneedles
suitable
implantable
Microneedles‐assisted
delivery
can
be
primarily
classified
passive,
active,
responsive
release,
release
mechanisms.
oral
mechanisms
also
presented
in
this
review.
Furthermore,
key
frontier
developments
microneedles‐mediated
major
selling
points
emphasized
These
into
open‐loop
closed‐loop
indirectness
directness
feedback
between
diagnosis
therapy,
respectively.
Finally,
conclusions
future
perspectives
next‐generation
discussed.
Taken
together,
microneedle‐based
new
avenue
disease‐specific
applications.
Lab on a Chip,
Journal Year:
2023,
Volume and Issue:
23(5), P. 869 - 887
Published: Jan. 1, 2023
This
review
summarizes
state-of-the-art
microneedle-based
detection
and
sensing
systems,
highlighting
the
objective
significance,
principles,
systematic
construction,
validation
models
of
these
microneedles.